IL17A and ankylosing spondylitis: The analysis shows that IL-17 polymorphisms are associated with clinical parameters in Polish patients with ankylosing spondylitis and have influence on AS severity and potential course of the disease and may be biomarkers of response to anti-TNF drugs in Polish patients.